{"id":24073,"date":"2023-08-17T10:00:28","date_gmt":"2023-08-17T08:00:28","guid":{"rendered":"https:\/\/idibell.cat\/?p=24073"},"modified":"2023-07-27T11:14:43","modified_gmt":"2023-07-27T09:14:43","slug":"lidibell-participa-en-el-projecte-oncodir-financat-per-la-ue-per-millorar-la-prevencio-del-cancer-colorectal","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/08\/lidibell-participa-en-el-projecte-oncodir-financat-per-la-ue-per-millorar-la-prevencio-del-cancer-colorectal\/","title":{"rendered":"L’IDIBELL participa en el projecte ONCODIR finan\u00e7at per la UE per millorar la prevenci\u00f3 del c\u00e0ncer colorectal"},"content":{"rendered":"

El c\u00e0ncer colorectal \u00e9s un tipus de c\u00e0ncer molt freq\u00fcent i sovint est\u00e0 relacionat amb h\u00e0bits de vida no saludables, especialment en poblacions amb un nivell socioecon\u00f2mic m\u00e9s baix. Ara, el projecte ONCODIR desenvolupar\u00e0 mesures preventives personalitzades utilitzant metodologies de recerca avan\u00e7ades, com l’an\u00e0lisi de pol\u00edtiques de salut, les ci\u00e8ncies socials i del comportament, l’\u00fas de la intel\u00b7lig\u00e8ncia artificial en l’estudi de les dades multi\u00f2miques i l’an\u00e0lisi de dades retrospectives.<\/p>\n

L’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) participar\u00e0 en aquesta ambiciosa iniciativa liderada pel Centre de Recerca i Tecnologia Hellas (CERTH) a Gr\u00e8cia i integrada per 27 socis d’\u00e0mbits de recerca com la biomedicina, la tecnologia, les ci\u00e8ncies socials i les humanitats. El consorci ha rebut finan\u00e7ament de l’Ag\u00e8ncia Executiva Europea de Salut i Digital (HADEA) en el marc de la Missi\u00f3 contra el C\u00e0ncer de la Comissi\u00f3 Europea.<\/p>\n

L’objectiu principal de ONCODIR \u00e9s oferir programes de prevenci\u00f3 del c\u00e0ncer basats en l’evid\u00e8ncia i enfocaments innovadors de prevenci\u00f3 personalitzats basats en IA. En aquest sentit, el projecte pret\u00e9n desenvolupar serveis de recomanaci\u00f3 que s’adaptin a les necessitats i prefer\u00e8ncies espec\u00edfiques dels ciutadans, actors de les pol\u00edtiques de salut i experts en ci\u00e8ncies socials.<\/p>\n

Mitjan\u00e7ant tallers de design thinking<\/em>, es garantir\u00e0 que les solucions desenvolupades siguin cocreades i dissenyades conjuntament, amb un enfocament especial en abordar aspectes cr\u00edtics com l’estil de vida, la nutrici\u00f3 i els h\u00e0bits socials. A m\u00e9s a m\u00e9s, s’atendr\u00e0 la identitat i l’\u00e8tica culturals, econ\u00f2miques, sociol\u00f2giques i les particularitats locals o regionals, i es tindran en compte la rendibilitat i l’assequibilitat dels programes de prevenci\u00f3 proposats. El pla de treball de 42 mesos est\u00e0 estructurat per incloure un enfocament hol\u00edstic i els resultats es validaran mitjan\u00e7ant experiments al laboratori i programes pilot en cinc pa\u00efsos.<\/p>\n

\u201cFormar part del projecte ONCODIR representa una oportunitat inigualable per crear intervencions amb un gran impacte a la prevenci\u00f3 preco\u00e7 del c\u00e0ncer colorectal\u201d, afirma el Dr. Josep Maria Borr\u00e0s, cap del grup de Recerca en Serveis de Sanitaris en C\u00e0ncer<\/a> de l’IDIBELL. Qui continua: \u201cEl nostre enfocament implica involucrar a totes les parts interessades, inclosos els ciutadans, els metges i els responsables pol\u00edtics, en el proc\u00e9s de co-disseny. Aix\u00f2 garanteix que les solucions basades en l’evid\u00e8ncia que desenvolupem s’adoptin f\u00e0cilment i s’apliquin de manera efica\u00e7 a les pol\u00edtiques sanit\u00e0ries, beneficiant finalment la vida de les persones en risc”.<\/p>\n

ONCODIR: “Evidence-based Participatory Decision Making for Cancer Prevention through Implementation Research.”<\/em><\/p>\n

Aquest projecte rep finan\u00e7ament de l’Ag\u00e8ncia Executiva Europea de Salut i Digital (HADEA) en el marc de la missi\u00f3 contra el c\u00e0ncer de la Comissi\u00f3 Europea, en virtut de l’acord de subvenci\u00f3 n\u00famero 101104777.<\/em><\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Liderat pel Centre de Recerca i Tecnologia Hellas (CERTH) a Gr\u00e8cia, el projecte compta amb 27 socis de diferents \u00e0mbits de recerca. Aquesta iniciativa integra metodologies d’avantguarda impulsades per la intel\u00b7lig\u00e8ncia artificial per oferir enfocaments personalitzats i basats en l’evid\u00e8ncia per prevenir aquest tipus de c\u00e0ncer.<\/p>\n","protected":false},"author":8,"featured_media":24074,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-24073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2024-12-29 19:25:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=24073"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24073\/revisions"}],"predecessor-version":[{"id":24075,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/24073\/revisions\/24075"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/24074"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=24073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=24073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=24073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}